Literature DB >> 24142230

Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells.

Shomron Ben-Horin1, Sylvie Polak-Charcon, Iris Barshack, Orit Picard, Ella Fudim, Miri Yavzori, Camila Avivi, Corine Mardoukh, Avichai Shimoni, Yehuda Chowers, Yaakov Maor.   

Abstract

PURPOSE: To elucidate the relative role of the immune system and intestinal epithelium in the ethiopatogenesis of Celiac disease (CD).
METHODS: A patient with childhood CD who underwent allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia was followed for 5 years after resumption of gluten containing diet. Immunological memory to gliadin epitopes was assessed in the index patient and in 5 newly diagnosed CD patients by standard serology testing and by CFSE-based proliferation assays of peripheral blood CD4+ cells and of intestinal LPL towards gliadin-TTG antigens. Intestinal lymphocytes' origin was determined by combined immuno-histochemistry and fluorescent in-situ hybridiazation (FISH).
RESULTS: Over 5 years of follow-up after receiving BMT from a HLA-matched woman and cessation of gluten-free diet, the patient has remained well, with negative periodic antibodies assays and unremarkable serial duodenal biopsies. In vitro proliferation assays showed lack of a memory response of the patient's peripheral blood and lamina propria CD4+ T-cells towards TTG, gliadin or TTG-treated gliadin, whereas memory responses were evident in the newly diagnosed CD patients. Immuno-FISH of post-BMT duodenal mucosa showed that the chromosomal phenotype of all the epithelial cells was XY. In contrast, CD45+ lymphocytic lineage cells were all donor-derived XX cells, presumably originating in the transplanted bone marrow and re-populating the intestinal wall.
CONCLUSIONS: CD resolution following allogeneic BMT is associated with absent gliadin-specific memory response, and with a dichotomous lymphocyte-epithelial chimeric intestine. These observations suggest that the pathogenesis of CD is critically dependent upon the immune system rather than the epithelial compartment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24142230     DOI: 10.1007/s10875-013-9943-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

Review 1.  Celiac disease: pathogenesis of a model immunogenetic disease.

Authors:  Martin F Kagnoff
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

3.  Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease.

Authors:  Michael Schumann; Dorothee Günzel; Nataly Buergel; Jan F Richter; Hanno Troeger; Claudia May; Anja Fromm; Detlef Sorgenfrei; Severin Daum; Christian Bojarski; Martine Heyman; Martin Zeitz; Michael Fromm; Joerg-Dieter Schulzke
Journal:  Gut       Date:  2011-08-24       Impact factor: 23.059

4.  T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).

Authors:  J O'Keeffe; K Mills; J Jackson; C Feighery
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

5.  Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease.

Authors:  Karen E Thomas; Anna Sapone; Alessio Fasano; Stefanie N Vogel
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

6.  Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.

Authors:  Tamara Matysiak-Budnik; Georgia Malamut; Natacha Patey-Mariaud de Serre; Etienne Grosdidier; Sylvie Seguier; Nicole Brousse; Sophie Caillat-Zucman; Nadine Cerf-Bensussan; Jacques Schmitz; Christophe Cellier
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

7.  Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation.

Authors:  M J Bargetzi; A Schönenberger; A Tichelli; R Fried; G Cathomas; E Signer; B Speck; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  1997-10       Impact factor: 5.483

8.  Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis.

Authors:  M C Wapenaar; A J Monsuur; A A van Bodegraven; R K Weersma; M R Bevova; R K Linskens; P Howdle; G Holmes; C J Mulder; G Dijkstra; D A van Heel; C Wijmenga
Journal:  Gut       Date:  2007-11-07       Impact factor: 23.059

9.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

Authors:  Sophie Hüe; Jean-Jacques Mention; Renato C Monteiro; ShaoLing Zhang; Christophe Cellier; Jacques Schmitz; Virginie Verkarre; Nassima Fodil; Seiamak Bahram; Nadine Cerf-Bensussan; Sophie Caillat-Zucman
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

10.  Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease.

Authors:  Jean-Jacques Mention; Mélika Ben Ahmed; Bernadette Bègue; Ullah Barbe; Virginie Verkarre; Vahid Asnafi; Jean-Frédéric Colombel; Paul-Henri Cugnenc; Frank M Ruemmele; Elisabeth McIntyre; Nicole Brousse; Chistophe Cellier; Nadine Cerf-Bensussan
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

View more
  1 in total

Review 1.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.